Assenagon Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-554,658
| Closed | -$46.3M | – | 1352 |
|
|
2023
Q4 | $46.3M | Buy |
+554,658
| New | +$46.3M | 0.12% | 126 |
|
|
2023
Q3 | – | Sell |
-101,327
| Closed | -$3.31M | – | 1352 |
|
|
2023
Q2 | $3.31M | Buy |
101,327
+66,709
| +193% | +$2.18M | 0.01% | 575 |
|
|
2023
Q1 | $1.22M | Buy |
+34,618
| New | +$1.22M | ﹤0.01% | 961 |
|
|
2022
Q3 | – | Sell |
-589,274
| Closed | -$23.2M | – | 1333 |
|
|
2022
Q2 | $23.2M | Sell |
589,274
-900,678
| -60% | -$35.4M | 0.09% | 186 |
|
|
2022
Q1 | $54.8M | Buy |
1,489,952
+1,445,969
| +3,288% | +$53.2M | 0.15% | 105 |
|
|
2021
Q4 | $2.01M | Sell |
43,983
-41,134
| -48% | -$1.88M | 0.01% | 791 |
|
|
2021
Q3 | $3.04M | Sell |
85,117
-113,516
| -57% | -$4.06M | 0.01% | 537 |
|
|
2021
Q2 | $3.93M | Sell |
198,633
-32,399
| -14% | -$641K | 0.01% | 505 |
|
|
2021
Q1 | $5.37M | Buy |
+231,032
| New | +$5.37M | 0.02% | 459 |
|
|
2020
Q4 | – | Sell |
-137,453
| Closed | -$2.98M | – | 1026 |
|
|
2020
Q3 | $2.98M | Buy |
+137,453
| New | +$2.98M | 0.02% | 455 |
|
|
2020
Q2 | – | Sell |
-121,510
| Closed | -$1.43M | – | 1105 |
|
|
2020
Q1 | $1.43M | Buy |
+121,510
| New | +$1.43M | 0.01% | 407 |
|
|
2019
Q4 | – | Sell |
-60,583
| Closed | -$689K | – | 759 |
|
|
2019
Q3 | $689K | Buy |
+60,583
| New | +$689K | ﹤0.01% | 603 |
|